Metraipolis › archive › dc_5cbf5a3abbfa

Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance — Europe PMC PMID:42798757

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42798757
DOI
10.3389/fonc.2026.1848165
License (as archived)
solo-consultazione
Archived
2026-10-10T04:05:57.125Z
SHA-256 of the archived text
b78d743c13fac2b9c3bfb2e41568309c87cc39c022adba7a3722ac17544641c8
Stable URL of this page
https://metraipolis.com/documento/dc_5cbf5a3abbfa

How to cite

Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance — Europe PMC PMID:42798757 — Europe PMC (en), https://europepmc.org/article/MED/42798757 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cbf5a3abbfa (Metraipolis archive dc_5cbf5a3abbfa, sha256 b78d743c13fac2b9c3bfb2e41568309c87cc39c022adba7a3722ac17544641c8)
BibTeX
@misc{dc5cbf5a3abbfa,
  title = {Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance — Europe PMC PMID:42798757},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42798757},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cbf5a3abbfa; sha256 b78d743c13fac2b9c3bfb2e41568309c87cc39c022adba7a3722ac17544641c8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798757. Agents can read the archived copy with the MCP tool read_document.